Eduardo Urias
Eduardo Urias
UNU-MERIT | Vrij Universiteit Amsterdam
Verified email at merit.unu.edu
Title
Cited by
Cited by
Year
Access to critical medicines: When are compulsory licenses effective in price negotiations?
SV Ramani, E Urias
Social Science & Medicine 135, 75-83, 2015
302015
Recursos naturais e desenvolvimento: estudos sobre o potencial dinamizador da mineração na economia brasileira
J Furtado, E Urias
IBRAM-Instituto Brasileiro de Mineração, 2013
242013
High-value hi-tech product introduction in emerging countries
SV Ramani, A Thutupalli, E Urias
Qualitative Market Research: An International Journal, 2017
162017
Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is there an Innovation System on the way?
E Urias, J Furtado
Value in Health 12 (7), A509, 2009
122009
Improving access to HIV/AIDS treatment in Brazil: when are compulsory licenses effective in price negotiations?
EMP Urias
Datawyse/Universitaire Pers Maastricht, 2015
82015
A industria farmaceutica brasileira: um processo de co-evolução de instituições, organizações industriais, ciencia e tecnologia
E Urias
Universidade Estadual de Campinas (UNICAMP), 2009
82009
When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil
SV Ramani, E Urias
Research Policy 47 (8), 1538–1552, 2018
62018
Evolução da indústria farmacêutica no Brasil: elementos para uma caracterização dos movimentos recentes, com ênfase nas políticas de inovação
J Furtado, EA URIAS
São Paulo, 2009
62009
The potential synergies between industrial and health policies for access to medicines: insights from the Brazilian policy of universal access to HIV/AIDS treatment
E Urias
Innovation and Development 9 (2), 245-260, 2019
42019
As Mudanças Recentes nas Estratégias Produtivas e Tecnológicas dos Laboratórios Farmacêuticos Instalados no Brasil: Uma Análise a partir dos Impactos Originados pela …
E Urias
UNESP/FCLAr, Departamento de Economia, 2006
42006
The contribution of the pharmaceutical industry to the health status of the developing world
E Urias
Multinational Enterprises and Sustainable Development, 2017
32017
Quantity vs. quality: an assessment of the current pipeline for rabies
AMG Neevel, E Urias, E Claassen, LHM van de Burgwal
Tropical Medicine & International Health 25 (4), 397-407, 2020
12020
A Thematic Approach to Realize Multidisciplinary Community Service-Learning Education to Address Complex Societal Problems: A-Win-Win-Win Situation
G Tijsma, E Urias, M Zweekhorst
Front. Educ. 5: 617380. doi: 10.3389/feduc, 2021
2021
Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence
E Urias, SV Ramani
Journal of International Business Policy 3 (4), 367-384, 2020
2020
A framework for Science Shop processes: Results of a modified Delphi study
E Urias, F Vogels, S Yalcin, R Malagrida, N Steinhaus, M Zweekhorst
Futures 123, 102613, 2020
2020
The brazilian pharmaceutical industry : a co-evolution process between science, technology, institutuions and industrial organizations
E Urias
he brazilian pharmaceutical industry : a co-evolution process between …, 2010
2010
Estudio sectorial: sector farmacéutico de Brasil; informe final-políticas regionales de innovación en el MERCOSUR: obstáculos y oportunidades
J Furtado, E Urias
Centro de Estudios sobre Ciencia, Desarrollo y Educación Superior (Centro …, 2010
2010
When access to drugs meets catch-up: insights from the use of compulsory licensing threats to improve access to ARVs in Brazil
SV Ramani, E Urias
The system can't perform the operation now. Try again later.
Articles 1–18